A telehealth prescription can feel like a mystery the first time you try it. You fill out a form online. Then you wait, unsure who is really reviewing your answers.
You may wonder if this is even allowed. You may ask who writes the prescription, and whether they are licensed where you live. These are smart questions to ask.
This guide walks through how online prescribing works, step by step. You will see what happens at each stage, from the first form to follow-up care. You will also learn how to spot a safe service.
KEY TAKEAWAYS
- A telehealth prescription comes from a licensed prescriber after a real medical review, not a form alone.
- The prescriber must hold a license in the state where you are during the visit.
- Visits can be live (synchronous) or store-and-forward (asynchronous), and some states require a live visit.
- GLP-1 medicines like Wegovy® and Zepbound® are not controlled substances, so the in-person rule does not apply.
- peptides.io reviews and compares providers; it does not prescribe, dispense, or ship any medicine
What readers want to figure out
- You want to know how a prescription can come from an online visit.
- You want the exact steps, from the first form to the pharmacy.
- You want to know if a video visit is required, or a questionnaire is enough.
- You want to be sure the prescriber is licensed in your state.
- You want to tell a safe telehealth service from a risky one.
What a telehealth prescription really is
A telehealth prescription is a normal prescription. The difference is how you meet the prescriber. You connect by video, phone, or secure messaging instead of in person.
The rules are mostly the same as an in-clinic visit. A licensed clinician must review your health before writing anything. That review is the heart of safe online prescribing.
You still get real medical care in this model. The visit may look different from a clinic visit. The safety checks behind it stay the same.
peptides.io is not a clinic or a pharmacy. It is an independent editorial review platform that compares telehealth providers. The care itself always comes from a licensed provider, not from this site.
How online prescribing works, step by step
Most telehealth services follow the same basic path. The names may change, but the stages are similar. Here is what usually happens.
- Online intake questionnaire. You share your health history, current medicines, allergies, and goals through a secure form.
- Medical evaluation. A clinician reviews your answers, and may request a video visit, photos, or lab results.
- Licensed prescriber review. A prescriber licensed in your state decides if the medicine is appropriate for you.
- Prescription, if appropriate. If it is a good fit, the prescriber sends a prescription to a pharmacy.
- Pharmacy fulfillment and shipping. A licensed pharmacy fills the order and ships it to your door.
- Follow-up and titration support. Your care team checks in, answers questions, and adjusts your dose over time.
The intake questionnaire is more than a sign-up form. It asks about your health history, current medicines, and any past reactions. Honest answers help the prescriber keep you safe.
The medical evaluation is the key safety step. A clinician looks for reasons a medicine may not be safe for you. They check your history, other medicines, and any warning signs.
The steps can also blend together. Some services handle everything by secure messaging. Others add a short video call when a prescriber wants to speak with you.
Asynchronous vs synchronous visits
Online visits come in two main styles. The difference is timing. One happens live, and one happens over time.
A synchronous visit is a real-time talk with a clinician. It can be a video call, a phone call, or a live chat. HHS describes it as a live interaction that often ends with a plan or prescription.
An asynchronous visit is store-and-forward care. You send your information, and the clinician reviews it later. HHS notes this style is often used for intake or follow-up.
Both can be valid ways to prescribe. Still, rules vary. Some states require a live visit before a prescriber can prescribe certain medicines.
Why do some states prefer a live visit? A real-time talk lets a clinician confirm who you are and ask follow-up questions. It can also catch details a short form might miss.
| Feature | Asynchronous (store-and-forward) | Synchronous (live visit) |
|---|---|---|
| What it is | You send info, the clinician reviews it later | A live video, phone, or chat visit in real time |
| Best for | Intake forms and routine follow-up | New concerns or when a live exam helps |
| Scheduling | Flexible, no set appointment | A set time you both join |
| State rules | Some states limit prescribing this way | Widely accepted, some states require it |
The heart of a telehealth prescription is a real medical review by a licensed prescriber, not the form you fill out.
Why your state matters
Where you live shapes your options. A prescriber must hold a license in the state where you are during the visit. This is a core telehealth rule from HHS.
This is why availability can change from state to state. A provider may serve one state today and add others later. Coverage grows as providers gain more state licenses.
Many states share a shortcut called the Interstate Medical Licensure Compact. More than 35 states take part as of 2026. It helps qualified doctors get licensed in several states faster.
Most states also want a real patient and provider relationship first. An online questionnaire alone usually does not count. The prescriber needs enough history to make a safe choice.
What if no provider serves your state yet? You may need to wait, or check back as coverage expands. A provider comparison can show which services cover your state today.
Are GLP-1 medicines controlled substances?
This question comes up a lot, so here is a clear answer. GLP-1 medicines are not controlled substances. That group includes Wegovy®, Zepbound®, Ozempic®, and Mounjaro®.
A federal law called the Ryan Haight Act sets extra rules for controlled substances online. It can require an in-person exam first. Because GLP-1 medicines are not controlled, that specific rule does not apply to them.
A prescriber still needs an active state license to prescribe them. State telehealth rules still apply. So a proper medical review is always part of the process.
These brands are approved for real medical uses. In the STEP 1 trial, adults on Wegovy® (the brand of semaglutide) lost about 14.9% of their weight over 68 weeks (N=1,961). In SURMOUNT-1, adults on Zepbound® (the brand of tirzepatide) lost up to 22.5% at the highest dose (N=2,539).
These trial results apply to the FDA-approved branded products only. A telehealth provider can explain what each medicine is approved to do.
What legitimate telehealth looks like
Most telehealth services are careful and legitimate. A few are not. Knowing the difference helps you stay safe.
Legitimate services share a few clear signs. They ask about your full health history. They use a licensed prescriber and a licensed pharmacy.
- A licensed prescriber reviews your health before any prescription.
- The prescriber is licensed in your state.
- A licensed pharmacy fills and ships your medicine.
- You can reach a real person with questions.
- Clear privacy terms explain how your data is used.
Some sites skip these steps. The FDA warns about online sellers that cut corners. Its BeSafeRx program lists warning signs to watch for.
- No medical evaluation, or a form with no real review.
- No licensed prescriber involved in the decision.
- No licensed pharmacist available to answer questions.
- The site sells medicine with no prescription needed.
- Deep discounts or offers that seem too good to be true.
If you spot these signs, walk away. You can check a pharmacy license with the FDA BeSafeRx tool. When in doubt, pick a service that names its prescriber and pharmacy.
A safe service always puts a licensed prescriber and a licensed pharmacy between you and your medicine.
What peptides.io does, and does not, do
It helps to be clear about roles. peptides.io is an independent editorial review platform. It reviews and compares telehealth providers so you can choose with confidence.
This is a common setup across health websites. A review platform points you toward strong options. The licensed provider then delivers the visit, the prescription, and the medicine.
peptides.io does not prescribe, dispense, or compound any medicine. It does not process payments, collect shipping details, or verify your eligibility. Licensed telehealth partners handle all of that.
So your prescription, your medicine, and your care come from the provider. peptides.io simply helps you compare your options. You can explore those options in our provider comparison.
The Bottom line
A telehealth prescription is a real prescription with an online front door. A licensed prescriber, licensed in your state, must review your health first. The medicine then ships from a licensed pharmacy, with follow-up care along the way.
Safe services keep a licensed prescriber and pharmacy in the loop at every step. peptides.io does not provide that care. It helps you compare the providers who do.
FREQUENTLY ASKED QUESTIONS
A telehealth prescription is a regular prescription written after an online medical visit. A licensed clinician reviews your health by video, phone, or secure messaging. If the medicine is a good fit, the prescriber sends it to a pharmacy. The main difference from a clinic visit is that you connect online instead of in person.
It depends on your state and the medicine. Many states say an online questionnaire alone is not enough to prescribe. The prescriber needs a real picture of your health first. Some states require a live video or phone visit before a prescription. Others allow store-and-forward review, where the clinician reads your information and responds later.
Yes. This is one of the most important telehealth rules. The prescriber must hold a license in the state where you are located during the visit. HHS is clear on this point. It is also why provider availability can differ from one state to another. As providers add more state licenses, they can serve more people.
No. GLP-1 medicines are not controlled substances, and they carry no DEA schedule. That group includes Wegovy®, Zepbound®, Ozempic®, and Mounjaro®. Because they are not controlled, the Ryan Haight Act in-person exam rule does not apply to them. A prescriber still needs an active state license, and a proper medical review is always required.
After the prescriber approves your prescription, it goes to a licensed pharmacy. The pharmacy fills the order and ships it to your address. Some services use a mail-order pharmacy, so your medicine arrives at home. You will usually get tracking updates along the way. If anything looks wrong with your package, contact the pharmacy or service right away.
Good telehealth care does not stop at the first prescription. Your care team usually checks in to see how you feel. For medicines like Wegovy® and Zepbound®, prescribers often start at a low dose. They step the dose up slowly over several weeks to limit side effects. You can message your team with questions between check-ins.
Look for a few clear signs. A legitimate service reviews your health history before writing any prescription. It uses a licensed prescriber and a licensed pharmacy. You can reach a real person with questions, and the privacy terms are clear. The FDA BeSafeRx program warns about sites that skip the exam or sell medicine with no prescription.
The intake questionnaire collects the basics a prescriber needs. It usually asks about your health history, current medicines, allergies, and past reactions. It may ask about your goals and family history too. Some services also request recent lab results or a photo. Honest, complete answers help the prescriber make a safe choice for you.
KEEP READING
Compare the best GLP-1 telehealth providers
See how top telehealth providers stack up on prescriber model, state coverage, and follow-up support, side by side.
→ Read next: /compare/best-glp-1-providers/
SOURCES
1. Telehealth.HHS.gov. Licensing across state lines. https://telehealth.hhs.gov/licensure/licensing-across-state-lines
2. Telehealth.HHS.gov. Synchronous direct-to-consumer telehealth. https://telehealth.hhs.gov/providers/best-practice-guides/direct-to-consumer/synchronous-direct-to-consumer-telehealth
3. Telehealth.HHS.gov. Asynchronous direct-to-consumer telehealth. https://telehealth.hhs.gov/providers/best-practice-guides/direct-to-consumer/asynchronous-direct-to-consumer-telehealth
4. Center for Connected Health Policy. State telehealth policies for online prescribing. https://www.cchpca.org/topic/online-prescribing/
5. American Medical Association. Establishment of a patient-physician relationship via telemedicine (state chart). https://www.ama-assn.org/system/files/2018-10/ama-chart-telemedicine-patient-physician-relationship.pdf
6. Federal Register. Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications. 2025. https://www.federalregister.gov/documents/2025/12/31/2025-24123/fourth-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled
7. American Psychiatric Association. Online prescribing of controlled substances (Ryan Haight Act). https://www.psychiatry.org/psychiatrists/practice/telepsychiatry/toolkit/ryan-haight-act
8. U.S. Food and Drug Administration. BeSafeRx: Your source for online pharmacy information. https://www.fda.gov/drugs/buying-using-medicine-safely/besaferx-your-source-online-pharmacy-information
9. U.S. Food and Drug Administration. How to buy medicines safely from an online pharmacy. https://www.fda.gov/consumers/consumer-updates/how-buy-medicines-safely-online-pharmacy
10. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
11. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022. https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
12. Interstate Medical Licensure Compact. About the Compact. https://www.imlcc.org/
Last updated: 2026-07-09 · Editorially reviewed by the Peptides.io team
Comments